Anjian Xu1,2, Tingxia Lv1,2, Bei Zhang1,2, Wei Zhang2,3, Xiaojuan Ou2,3, Jian Huang1,2. 1. Experimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China. 2. National Clinical Research Center for Digestive Disease, Beijing Friendship Hospital, Capital Medical University, Beijing, China. 3. Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Abstract
BACKGROUND: Wilson's disease (WD) is a rare autosomal recessive disorder characterized by the deposition of copper mainly in the liver or nerve system that leads to their dysfunction. Mutations in the gene encoding ATPase, Cu+ transporting, beta polypeptide (ATP7B) are causative for WD. The aim of this study was to develop a rapid and convenient assay for detection of the three most common causative ATP7B mutations, p.R778L, p.P992L, and p.V1106I. METHODS: Plasmids containing DNA fragments harboring each of the three ATP7B mutations were constructed. High-resolution melting (HRM) analysis was conducted by asymmetric polymerase chain reaction (PCR) amplification with paired primer and unlabeled probe, performed in a 96-well plate formatted LightCycler 480 Real-Time PCR System. The assay was evaluated for accuracy and reproducibility by genotyping of 41 WD cases. RESULTS: The unlabeled probe HRM assays performed on constructs with the p.R778L, p.P992L, and p.V1106I mutations in the ATP7B gene resulted in additional melting peaks. According to the unlabeled probe HRM molecular signature, we could differentiate homozygous mutations from wild-type with the ΔTm (difference between melting temperatures) >4°C, and the coefficient of variation in repeatability tests was <5%. In the validation assay using our method to examine clinical samples, a 100% accuracy rate was achieved. CONCLUSIONS: The newly developed assay to rapidly genotype the ATP7B mutations is convenient, accurate, and reproducible, and represents a favorable alternative to Sanger sequencing in the identification of specific ATP7B mutations.
BACKGROUND:Wilson's disease (WD) is a rare autosomal recessive disorder characterized by the deposition of copper mainly in the liver or nerve system that leads to their dysfunction. Mutations in the gene encoding ATPase, Cu+ transporting, beta polypeptide (ATP7B) are causative for WD. The aim of this study was to develop a rapid and convenient assay for detection of the three most common causative ATP7B mutations, p.R778L, p.P992L, and p.V1106I. METHODS: Plasmids containing DNA fragments harboring each of the three ATP7B mutations were constructed. High-resolution melting (HRM) analysis was conducted by asymmetric polymerase chain reaction (PCR) amplification with paired primer and unlabeled probe, performed in a 96-well plate formatted LightCycler 480 Real-Time PCR System. The assay was evaluated for accuracy and reproducibility by genotyping of 41 WD cases. RESULTS: The unlabeled probe HRM assays performed on constructs with the p.R778L, p.P992L, and p.V1106I mutations in the ATP7B gene resulted in additional melting peaks. According to the unlabeled probe HRM molecular signature, we could differentiate homozygous mutations from wild-type with the ΔTm (difference between melting temperatures) >4°C, and the coefficient of variation in repeatability tests was <5%. In the validation assay using our method to examine clinical samples, a 100% accuracy rate was achieved. CONCLUSIONS: The newly developed assay to rapidly genotype the ATP7B mutations is convenient, accurate, and reproducible, and represents a favorable alternative to Sanger sequencing in the identification of specific ATP7B mutations.
Authors: Annika M Svensson; Lan-Szu Chou; Cindy Meadows; Christine E Miller; Robert Palais; Kelli Sumner; Tyler C Wayman; Rong Mao; Elaine Lyon Journal: Genet Test Mol Biomarkers Date: 2011-01-23
Authors: Michael Liew; Robert Pryor; Robert Palais; Cindy Meadows; Maria Erali; Elaine Lyon; Carl Wittwer Journal: Clin Chem Date: 2004-07 Impact factor: 8.327
Authors: Tiffany R Hodges; Collin M Labak; Uma V Mahajan; Christina Huang Wright; James Wright; Gino Cioffi; Haley Gittleman; Eric Z Herring; Xiaofei Zhou; Kelsey Duncan; Carol Kruchko; Andrew E Sloan; Jill S Barnholtz-Sloan Journal: Neurooncol Adv Date: 2021-03-06